[Off-label use of biologic agents in the treatment of dermatosis, part 2: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab, and cetuximab] (Q80516806)
Jump to navigation
Jump to search
scientific article published on 01 January 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | [Off-label use of biologic agents in the treatment of dermatosis, part 2: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab, and cetuximab] |
scientific article published on 01 January 2008 |
Statements
[Off-label use of biologic agents in the treatment of dermatosis, part 2: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab, and cetuximab] (English)
G Guhl
B Díaz-Ley
J Fernández-Herrera